A shocking lab test has raised serious safety concerns after two vials sold as an experimental weight-loss drug revealed unexpected chemicals and live bacteria, with one sample reportedly containing 13 bacterial colonies.
Story Snapshot
- Reporters bought two “retatrutide” vials marketed to consumers and sent them to labs for testing.
- Tests found phenylacetic acid, a cheap filler linked to fragrance and illicit drug making.
- A separate lab found 13 bacterial colonies in one sample, a clear infection risk if injected.
- Federal regulators call these products unapproved drugs and warned multiple sellers.
What CBS Bought And What Labs Found
CBS News obtained two vials marketed online as retatrutide, a still-experimental weight loss drug from Eli Lilly, and sent them for testing. Chemist David Galpin reported the samples matched only a basic retatrutide reference he built, not the drug used in Eli Lilly clinical trials. He also detected phenylacetic acid, which he described as filler rather than verified medicine. A separate university lab cultured 13 bacterial colonies from one vial and warned that injection could cause infection.
The product label on at least one vial said “Research use only, not for human consumption,” yet it was offered in a way consumers could buy and use it. The Food and Drug Administration warns that sellers use such labels while still pitching human dosing and direct use, which can mislead buyers into thinking the sales are allowed. That mismatch between a lab label and a storefront pitch is a hallmark of the gray market around hot weight loss drugs.
Why This Matters For Your Health
Retatrutide is not approved for sale as a medicine today, so anything sold as such lives outside the drug safety system. The Food and Drug Administration warns that unapproved glucagon-like peptide drugs can contain the wrong ingredient, too much or too little of the right one, or none at all. The agency’s warnings match the CBS findings: a fragrance-linked chemical in the vial and live bacteria that no one should inject into their body.
Even one dirty vial can cause real harm. Bacteria in injectables can seed skin abscesses, bloodstream infections, and worse. Dosage errors can crash blood sugar or stress the heart. This is not a diet tea. This is a needle going past your skin barrier. The conservative, common-sense test applies: if you cannot name the factory, the formula, and the inspector, you shouldn’t put it in your body.
What Regulators And The Manufacturer Say
Federal warning letters to multiple peptide sellers state that retatrutide products are unapproved new drugs and illegal to market. The Food and Drug Administration cited violations of core drug law sections and ordered firms to stop sales. An agency list shows ongoing enforcement against peptide vendors, including those marketing weight loss compounds without approval. These actions confirm that vials sold online as “reta” are not lawful medicines under United States drug rules.
Eli Lilly draws a bright line between its clinical-trial retatrutide and black-market goods. The company says the drug is only in trials and has not been approved for human use. Its chief medical officer called the online versions “entirely unverified, unapproved,” and urged platforms and payment firms to shut the market down. That stance aligns with basic consumer protection: real drugs come through licensed channels, with lot tracking, sterility checks, and recall power.
How This Fits A Larger Pattern
High demand for weight loss shots has fueled a shadow market that swaps labels faster than it fixes quality. The Food and Drug Administration has cautioned for years that illegal weight loss products may hide the wrong ingredient, harmful fillers, or wildly wrong doses. Past crackdowns found substitution, not empty vials, including cases where supposed brand-name weight loss pills actually contained a different, risky drug. The CBS lab results sit squarely within that pattern of corner-cutting and contamination.
🇺🇸 A "miracle" weight loss shot from a Brooklyn bodega turned out to be fragrance filler and BACTERIA
CBS News bought retatrutide, an experimental drug Eli Lilly is still testing, from a clinic website, a gym and a corner store without ever talking to a doctor.
Lab tests showed… pic.twitter.com/dYvqFbMj25
— Mario Nawfal (@MarioNawfal) October 22, 2026
Practical steps protect you. Skip any vial sold with a “research only” sticker or a checkout page that looks like sneakers, not medicine. Check with your doctor and your pharmacist before you start any drug. Verify that the drug is FDA-approved and dispensed by a licensed pharmacy. If a price or promise seems magical, assume it is marketing, not medicine. Your health is not a test bench, and your kitchen is not a cleanroom.
Sources:
cbsnews.com, fda.gov, investor.lilly.com
